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Background The level of frailty in the older population
across age cohorts and how this changes is a factor in
determining future care costs and may also inﬂuence the
extent of socioeconomic and gender inequalities in
frailty.
Methods We model cohort-speciﬁc trajectories in frailty
among the community dwelling population older than
50 years, using ﬁve waves (2002–2010) of the English
Longitudinal Study of Ageing. We stratify our analysis by
wealth and gender and use a frailty index, based on
accumulation of ‘deﬁcits’.
Results For males and females between the ages of 50
and 70 in 2002, frailty trajectories for adjacent age
cohorts converge. However, levels of frailty are higher in
recent compared with earlier cohorts at the older ages
(for cohorts aged over 70 in 2002). These cohort
differences are largest in the poorest wealth group, while
for the most afﬂuent, frailty trajectories overlap across all
adjacent cohorts suggesting no change across cohorts.
Conclusions A key driver of the cohort differences in
frailty that we observe is likely to be increased survival of
frail individuals. Importantly, this paper illustrates that
the social conditions experienced across the wealth
distribution impacts on the rate of deﬁcit accumulation
in older populations. Our results on trajectories of frailty
between 2002 and 2010 are pessimistic and, in the
context of rising life expectancies, suggest that poorer
older people in particular spend additional years of life
in a frail state.
INTRODUCTION
A fundamental question within ageing research is
whether the extension of life expectancy has been
accompanied by longer or shorter periods of
healthy life expectancy. Three theories have been
proposed.1–3 The compression of morbidity theory
argues that the onset of morbidity is delayed so that
as life expectancy increases people spend fewer
years of their life in poor health.1 It is argued that
the factors (such as improved nutrition, medical
advances and improvements in care, and less physic-
ally arduous working conditions) that drive the
trend of increasing longevity also delay the age at
onset of disabling conditions and slow the progres-
sion of such conditions. As a result the time spent in
poor health is compressed to the ﬁnal years of life.1
In contrast, the expansion of morbidity theory
gives a pessimistic outlook under which the age of
poor health onset remains roughly constant (or lags
improvements in longevity) so that gains in life
expectancy are composed mainly of increasing years
spent with chronic health problems.2 The mechan-
ism underlying this theory is that improvements in
modern medicine extend the lives of those with
chronic health problems and disabilities to a greater
degree than they slow the onset and progression of
such conditions.2 Additionally, it is argued that
where there are rises in unhealthy lifestyle choices
and associated conditions, such as obesity, in
younger compared with older cohorts, these may
have serious implications for age at onset of chronic
health problems, such as diabetes, providing an add-
itional contribution to the proposed expansion of
morbidity.4
Clearly, there is scope for aspects of both theor-
ies to operate and the receding horizon model falls
between the expansion and compression of mor-
bidity models and proposes that the onset and pro-
gression of morbidity is postponed to exactly the
same extent as death so that the number of years
spent in poor health remains unchanged.3
The ﬁndings of research into this issue vary accord-
ing to the health outcome, the type of data used
(cross-sectional or longitudinal), social class and
across countries, perhaps reﬂecting different social,
cultural and political contexts.4–11 Furthermore,
there is considerable uncertainty as to how health tra-
jectories at older ages might be affected by the chan-
ging prevalence of risk factors such as obesity,
sedentary lifestyles, smoking and alcohol consump-
tion.4 A weakness of existing studies, particularly in
the UK, is that they have tended to draw on repeated
cross-sectional data,12 13 which is problematic in
terms of the separation of age and cohort effects.
In this paper we model trajectories of frailty
among older, community-dwelling people in
England over the last decade (2002–2010) focusing
on inequalities according to gender and wealth. A
central aspect is the identiﬁcation of cohort differ-
ences: do people have a better (or worse) frailty
score relative to their counterparts in different
cohorts but at an equivalent age. Cohort improve-
ments in health over time have the potential to
reduce the costs associated with a more elderly
population,14 15 yet if these are concentrated
among the afﬂuent they will serve to exacerbate the
extent of health inequality. Our focus on frailty, a
multidimensional measure of health, offers a valu-
able contribution to the existing research on trends
in health that has tended to examine indicators of
single aspects of health.
Frailty has emerged as a key aspect in research on
population ageing and geriatric clinical practice.
While speciﬁc deﬁnitions and measures of frailty are
contested, there is general agreement that frailty is a
non-speciﬁc state reﬂecting age-related declines in
multiple systems, which lead to a range of adverse
outcomes such as falls, fractures, hospitalisation,
institutionalisation and mortality.16 Frailty is a
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useful outcome with which to consider the challenges of caring
for a growing elderly population; it provides an indication of an
individual’s capacity for independent living and the risk of suffer-
ing an adverse event, such as a fall, that might precipitate a need
for greater levels of care in the future. A number of measures of
frailty have been developed, including a frailty index which is
based on the number of ‘deﬁcits’ held by an individual and which
has been validated as a predictor of mortality and institutionalisa-
tion in the literature.16–19
In this paper we explore whether levels of dependency are
changing across cohorts by examining differences in trajectories
of frailty including stratiﬁcation by socioeconomic position and
gender. We use a frailty index derived using data from the




We model frailty trajectories among older people in the commu-
nity (age 50+). Each frailty trajectory comprises an estimate of the
mean level of frailty in 2002 and the subsequent change in frailty
over an 8-year period up to 2010. We derive distinct frailty trajec-
tories for seven cohorts based on an individual’s age in 2002 (50–
54, 55–59, 60–64, 65–69, 70–74, 75–79 and 80+). The cohort-
speciﬁc frailty trajectories overlap over the study period, enabling
comparison of the level and rate of change of frailty across cohorts
at equivalent ages (but different points in time). We consider
whether the cohort-speciﬁc trajectories converge, suggesting that
levels of frailty are unchanged across cohorts, or diverge, suggest-
ing improvement/deterioration in levels of frailty across cohorts.
Finally, we consider whether any cohort differences in frailty vary
according to gender and across wealth distribution.
Data
We use data from ﬁve waves of the ELSA collected between 2002
and 2010. ELSA is a representative sample of the population
aged 50 and over, living in private households in England and is
a rich data source containing information on sociodemographic
characteristics, health, social participation and biomarkers.20
The ELSA sample size at baseline in 2002 comprises 11 391
individuals (aged 50+) representing a response rate of 67%. Of
this sample, 11 220 participants (98%) have sufﬁcient non-
missing values across deﬁcit variables (30 or more of 60) for a
frailty index to be calculated. Encouragingly, over 95% of the
sample responded to at least 58 of the 62 deﬁcits in each wave
of the survey, a level of item response that holds for men and
women and across the wealth distribution. As for most longitu-
dinal studies, ELSA suffers from a degree of attrition (see online
supplementary information and table S1 for further details) as a
result of a range of factors such as mortality, non-response,
migration overseas, illness and institutionalisation, so that by
wave 5 the sample size is reduced to 6242. ELSA has an average
of 3.6 observations per individual (of a possible total of ﬁve).
The rich detail of the ELSA data set enables production of a
frailty index including 60 items covering a range of domains
(activities of daily living, cognitive function, falls and fractures,
joint replacement, vision, hearing, chronic diseases, cardiovascu-
lar diseases and depression). Following guidance in the literature
we only include individuals in our study if they have non-
missing values for at least 30 of the 60 frailty components.21 A
full list of the deﬁcits and their coding is provided in the online
supplementary material.
The key explanatory variables in this paper are an individual’s
age in the ﬁrst wave of ELSA (2002), according to quinary age
groups (cohort identiﬁer), gender and wealth. This wealth vari-
able includes the net ﬁnancial and physical wealth and the net
housing wealth for each household. We utilise a measure of
household rather than individual wealth because in the vast
majority of cases older couples deal with ﬁnances jointly.
Pension wealth is known to be particularly age dependent,
declining throughout an individual’s retirement22 and so we
exclude it from our analysis. We calculate wealth tertiles for
each cohort separately at wave 1 in order to accommodate
cohort-speciﬁc differences in ﬁnancial circumstances. The
sample characteristics at waves 1 and 5 are given in table 1; the
age and sex structure of the ELSA sample at wave 1 (2002) is in
line with the household population in the 2001 census. The
mean level and distribution of frailty is comparable with that
observed in other similar studies.18 21
Model
We ﬁt a series of multilevel growth curve models that predict
the level of frailty in wave 1 (2002) and the subsequent change
in frailty between waves 1 and 5 (2002–2010) dependent on
cohort at wave 1. Our multilevel model consists of repeated
observations nested within individuals, offering one way of
dealing with the non-independence of an individual’s level of
frailty over time. A key advantage of using a multilevel approach
is that the technique is capable of handling unequal time spaces,
missing data, and the inclusion of time varying and between-
subject covariates that are either continuous or discrete mea-
sures.23 We use a similar methodology to that in a study of
depression in later life24 to investigate whether cohorts share
the same or different frailty trajectories. We extend this method-
ology to consider whether cohort-speciﬁc trajectories differ by
gender and wealth.
The models ﬁtted are speciﬁed below (equations 1–5) where
FIti indicates the frailty index of individual i at time t for i=1…
11 220 and t=1…ti; ti is the number of repeated measures avail-
able for individual i and ranges from 1 to 5 depending on the
number of survey waves that an individual participated in (see
online supplementary material for more details on missingness).
In the level 1 repeated measures model (equation 1), each indi-
vidual’s frailty trajectory is modelled as a function of time,
where timeti denotes the timing of occasion t for individual i
and is based on a centred version of survey wave (time=−2, −1,
0, 1, 2; see elsewhere for details on variable centring25). We
include a quadratic term, time2ti, to allow for the development
of non-linear frailty trajectories. Thus, in equation 1, the inter-
cept β0i gives the mean frailty index of person i in wave 3 while
β1i and β2i give the linear and quadratic growth of frailty over
time for individual i. In equation 1, eit is the random within-
person error for person i at time t, which is assumed to be nor-
mally distributed. The level 2 model (growth trajectories across
individuals) allows for a distinct trajectory for each age cohort
(equations 2 and 3). Here, cohorti indicates the cohort member-
ship of individual i and is treated as a (centred) continuous vari-
able taking the values −3, −2, −1, 0, 1, 2 and 3.
Operationalisation of cohort using dummy variables gives
similar results and identical conclusions. We experimented with
inclusion of a cohort squared term but this was not statistically
signiﬁcant so we did not include it in the models reported here.
In equation 2, γ00 is the mean frailty index at wave 3 of cohort
0 (65–69 years old in 2002).
Level 1 model (growth trajectory within individuals)
FIti ¼ b0i þ b1itimeti þ b2itime2ti þ eit ð1Þ
Marshall A, et al. J Epidemiol Community Health 2015;69:316–321. doi:10.1136/jech-2014-204655 317
Life course and long-term inﬂuences on health
Level 2 model (growth trajectory across individuals)
For the intercept:
b0i ¼ g00 þ g01cohorti þ u0i ð2Þ
For the slope:
b1i ¼ g10 þ g11cohortþ u1i ð3Þ
We develop the model above to allow frailty growth trajectories
for cohorts to vary according to gender and wealth tertiles (both
treated as time invariant). This involves the same level 1 model
as speciﬁed in equation 1 but equations 2 and 3 are adapted to
include an interaction between cohort and either wealth or
gender (see example below for gender differences in frailty tra-
jectories).
b0i ¼ g00 þ g01cohorti þ g02 femalei þ g03cohorti femalei
þ u0i ð4Þ
b1i ¼ g10 þ g11cohortþ g12 femalei þ g13cohorti femalei
þ u1i ð5Þ
All analyses are carried out in Stata/SE12.1. We include wave 1
cross-sectional weights to ensure that the sample is representa-
tive of the community-dwelling population aged over 50 in
2002. We also conducted sensitivity analysis to assess the impact
of attrition on our ﬁndings by ﬁtting the same models using
only those who participated in all ﬁve waves of ELSA, which
enabled us to use the provided survey weights that adjust for
attrition between waves 1 and 5. This sensitivity analysis (see
online supplementary material) did not affect any of our conclu-
sions and is referred to in the discussion.
RESULTS
Figure 1A–C displays vector graphs of the model frailty trajec-
tories with 95% CIs represented by dotted lines. The estimated
coefﬁcients that specify the trajectories are given in the online
supplementary material. In this paper, each line represents a
frailty trajectory for a particular cohort, which starts at the age
midpoint for that cohort in 2002 and then tracks the change in
frailty over the next 8 years until 2010. In ﬁgure 1A, we observe
little evidence of difference in levels of frailty across the recent
cohorts (from age 50 to 70 when ﬁrst observed in 2002).
However, there does appear to be a difference in frailty across
the earlier cohorts (starting from the age of 70 when ﬁrst
observed in 2002) with higher frailty in recent cohorts com-
pared with earlier cohorts. The same slope of frailty and the
patterns of cohort differences in frailty hold for men and
women (see ﬁgure 1B) suggesting that the differential of higher
frailty in women compared with men did not change between
2002 and 2010.
The wealth differences in levels of frailty shown in ﬁgure 1C
are stark; the average trajectory of frailty for an individual in
the richest tertile at age 80+ is comparable with that for an
individual at age 70–74 in the poorest tertile. Figure 1C suggests
that inequalities in levels of frailty widened between 2002 and
2010, at particular overlapping ages recent cohorts appear to
have higher levels of frailty compared with earlier cohorts
among the poorest tertile (take, eg, levels of frailty between the
ages of 75 and 80 for the cohort aged 70–74 in 2002 and the
cohort aged 75–79 in 2002), while for the richest there is little
difference in frailty across cohorts. A key driver of this wealth-
speciﬁc cohort difference is the slower estimated growth rate of
frailty for those in the richest tertile compared with the poorest
tertile (the interaction coefﬁcient: richest tertile×growth rate=
−0.001; p=0.03).
Table 1 Sample characteristics at the first and fifth wave of English Longitudinal Study of Ageing
Wave 1 (2002)















M/% SD M/% SD M/% SD M/% SD M/% SD M/% SD M/% SD M/% SD
Frailty Index 0.16 0.12 0.12 0.11 0.14 0.11 0.15 0.11 0.16 0.11 0.18 0.11 0.20 0.12 0.24 0.12
Age 65 10 52 1 57 1 62 1 67 1 72 1 77 1 84 4
Female 54% 50 55% 50 53% 50 52% 50 53% 0.50 54% 0.50 54% 50 62% 49
Poorest tertile 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47
Middle wealth tertile 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47
Richest wealth tertile 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47 33% 47
Wave 5 (2010)









(1030) 70–74 (727) 75–79 (451) 80+ (284)
M/% SD M/% SD M/% SD M/% SD M/% SD M/% SD M/% SD M/% SD
Frailty Index 0.18 0.13 0.13 0.11 0.15 0.11 0.17 0.12 0.19 0.12 0.23 0.13 0.27 0.14 0.34 0.16
Age 71 9 61 1 65 2 70 2 75 1 80 1 85 2 91 2
Female 56% 49 56% 50 54% 50 55% 50 56% 50 57% 50 59% 49 68% 46
Poorest tertile 28% 45 30% 46 28% 45 28% 45 27% 45 28% 45 25% 44 24% 43
Middle wealth tertile 34% 47 32% 47 36% 48 34% 47 35% 48 35% 48 34% 47 32% 47
Richest wealth tertile 38% 48 37% 48 36% 48 38% 49 37% 48 37% 48 41% 49 44% 50
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DISCUSSION
The analysis presented reveals a pessimistic set of ﬁndings con-
cerning trends in frailty between 2002 and 2010. There is no
evidence for improvement in levels of frailty across cohorts,
with a strong suggestion of higher levels of frailty among recent
cohorts compared with earlier cohorts (for those cohorts aged
over 70 in 2002), particularly for the poorest individuals. This
carries the negative implication that the continuing gains in life
expectancy are composed of additional years spent in frailty
with the potential for greater associated healthcare costs.
Inequalities in frailty across the wealth distribution are stark and
they appear to widen over the period 2002–2010; the increase
in frailty in recent cohorts compared with earlier cohorts is
most prominent among the poorest individuals with little evi-
dence of such cohort differences among the most afﬂuent.
Levels of frailty are higher for women than for men and the
analysis of cohort and gender-speciﬁc trajectories suggests that
this difference has remained unchanged over the study period.
The lack of evidence for improvement in levels of frailty
across most cohorts is in line with other UK-based research
(cross-sectional and longitudinal) that has found limited evi-
dence for improvements in various health outcomes from 1990s
to the present.12 13 26–28 A US-based study that examined
cohort-speciﬁc trajectories of frailty also reported higher levels
of frailty in recent cohorts compared with earlier cohorts29 and
similar ﬁndings are observed in the USA for cohort-speciﬁc tra-
jectories of self-reported illness.30 31 Our ﬁnding of different
slopes of frailty across cohorts is in line with a US-based study
of depression in later life.24 However, this study reported
cohort differences in levels of depression in the opposite direc-
tion to our ﬁndings for frailty with higher levels of depression
in earlier cohorts compared with recent cohorts. This illustrates
the potential for variability in cohort differences across different
domains of health.
The higher frailty we observe in recent cohorts compared
with earlier cohorts (for cohorts aged over 70 in 2002) may
reﬂect improvements in medical and care services across the life
course that increase the survival of frail individuals with the
effect most prominent at the oldest ages where risks of frailty
are highest. Additionally, these cohort differences in frailty
might also reﬂect real deterioration in the condition of older
people over time separate to any improvement in life expect-
ancy. One mechanism might be increases in the prevalence of
unhealthy lifestyle choices, which are concentrated in recent
cohorts compared with earlier cohorts. If such unhealthy life-
style choices have a cumulative effect over the life course and
are socially patterned then they have the potential to explain
the nature of the cohort differences that we observe, which are
strongest at the oldest ages and for the poorest individuals.
Analysis of ELSA data between 2004 and 200832 reveals mixed
evidence for this theory. First, while some unhealthy lifestyle
choices are most prevalent for the poorest individuals (such as
inactivity, fruit and vegetable consumption and smoking), for
others the social patterning is less clear (such as alcohol con-
sumption and obesity). Second, not all unhealthy lifestyle
choices are increasing in the age cohorts covered here.
Comparison of the cohort-speciﬁc extent of smoking and daily
alcohol consumption within ELSA reveals declines in prevalence
between 2004 and 2008, although there was an increase in the
prevalence of sedentary lifestyles and waist circumference over
this period. The review above points to the need for further
analysis on cohort-speciﬁc trends in speciﬁc unhealthy lifestyle
choices (including prior to the period of this study) in order to
fully understand their impact on the cohort differences in later
life frailty. We also need to consider the drivers of such changes
in lifestyle.
Social conditions appear to inﬂuence the rate of deﬁcit accu-
mulation in older populations, as has been noted in the USA.29
We observe faster cohort-speciﬁc growth in frailty among
poorer compared with richer individuals, widening the strong
inequalities observed in frailty at the start of the study in 2002.
This ﬁnding is supported by recent evidence on socioeconomic
trends in disability-free life expectancy at the older ages in
England; for example, at age 65, the years spent with a disabil-
ity increased between 2002–2005 and 2006–2009 in the most
deprived neighbourhoods but remained constant in the least
Figure 1 Frailty trajectories: (A) all people (aged 50+); (B) by gender
and (C) by wealth.
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deprived neighbourhoods.33 Income inequality in England
increased steeply during the 1980s and has been sustained
throughout the 1990s and 2000s at historically high levels.34 A
body of literature claims that the growth in health inequality
reﬂects trends in wealth inequality.35 The accumulation of stress
and disadvantage relating to social position across the life-
course36 combined with the growth in economic inequality in
England from the 1930s offers another explanation for the
cohort differences observed here for the poorest older people.
As has been previously predicted elsewhere,34 our analysis
reveals higher levels of frailty at the oldest ages for recent
cohorts compared with earlier cohorts, perhaps because they
have lived through a time of greater inequality with greater psy-
chological penalties associated with low social position com-
pared with later cohorts. While our results show that the extent
of the inequality in frailty across wealth tertiles is smallest at the
oldest ages, it is probable that selective mortality effects offer
one explanation for this observation.37
In this paper, as in other studies,38 we ﬁnd higher levels of
frailty for women compared with men. The growth of frailty
for cohorts is identical for men and women mirroring the
gender-speciﬁc dynamics of frailty observed in the USA.29 The
absence of differential frailty cohort effects between men and
women suggests that gender inequalities in frailty have not
diminished between 2002 and 2010. This stability in gender
frailty inequality is in line with that observed for physical health
and self-rated health (but not depression).30
This paper is subject to some limitations. First, although
accelerated cohort studies are regarded as the gold standard in
terms of analysing changes in health and functioning over time
and separating effects of age and cohort, they are subject to an
important limitation regarding the possibility that cohort effects
are actually attributable to period effects. Models that attempt
to separate age, period and cohort effects, including recent
developments, have been subjected to strong criticism,39 with
some arguing that it is impossible to separate all three inﬂu-
ences.40 We cannot exclude the possibility that a period effect
has some inﬂuence on the cohort differences we observe.
However, such a possibility is somewhat reduced given that the
period we study is relatively short (2002–2010).
Related to this, it is possible that changes in levels of institu-
tionalisation at the older ages might inﬂuence our results. In
England there has been a slight shift towards a greater propor-
tion of older people remaining within the community rather
than living in institutions between 2002 and 2010. Thus, at a
particular age, it is likely that an earlier cohort in wave 1 (2002)
had a slightly greater proportion of frail individuals within care
homes compared with a recent cohort in wave 5 (2010), where
institutional living is slightly less common. However, the level
of institutional living at older ages and the change over this
period is relatively small; the census estimates reveal that 4.6%
of the population aged over 65 were in institutions in 2001
compared with 3.7% in 2011. While levels of institutional
living are higher at the oldest ages the levels and change in the
proportions living in institutions are modest; 12.6% of the
population aged over 80 were in institutions in 2001 compared
with 10% in 2011. Thus, the changes in prevalence of institu-
tional living in later life are unlikely to be a key driver of the
cohort differences in frailty that we observe.
A further limitation of our study relates to attrition and the
tendency for those who drop out of the study to have different
characteristics to those who participate fully. Analysis of attrition
in ELSA illustrates that those who drop out are most likely to be
frail, older (members of an earlier birth cohort), male and poor
(see online supplementary material). It is logical that without
such attrition we would observe steeper frailty trajectories, from
the same starting point (weights for non-response in wave 1 are
included in the analysis), particularly so for the poor, earlier
birth cohorts and males. Consequently, the impact of attrition
on our frailty trajectories is likely to have minimised our main
ﬁndings; we might expect that accounting for attrition would
strengthen the deterioration we observe in frailty across cohorts,
making the possibility of improvement in frailty within recent
cohorts compared with earlier cohorts even more unlikely.
Similarly, the wealth differences in frailty across cohorts are
likely to be exacerbated if attrition was accounted for. In separ-
ate analysis that uses only those who participated in all ﬁve
waves of ELSA and that employs longitudinal weights to adjust
for attrition between waves 1 and 5, we ﬁnd comparable cohort
differences to those reported in this paper (see online
supplementary material).
Health inequalities are considered undesirable for many reasons
including fairness, the related adverse impacts on wider society,
the avoidable nature of health inequality and cost-effectiveness.41
This paper shows that the stark inequalities in frailty in later life
may well have widened between 2002 and 2010, and certainly
have not reduced. This trend is a concerning one that does not
bode well for the future. It points towards a further divergence in
health experiences in later life across wealth distribution as life
expectancies continue to increase. Effective policy responses to
this trend will require a strong political will as well as a clear
understanding of the drivers of inequality throughout the life
course. Crucially, the challenges of population ageing and health
inequalities should not be seen in isolation.
What is already known on this subject?
▸ Frailty at older ages is known to be associated with adverse
outcomes such as mortality, dependency and
institutionalisation.
▸ In later life, levels of frailty are higher for women compared
with men and there is a strong gradient of decreasing frailty
with increasing wealth.
▸ A recent study in the USA revealed a pessimistic ﬁnding of
higher levels of frailty in recent cohorts compared with
earlier cohorts at an equivalent age.
What this study adds?
▸ This study demonstrates that in England, recent cohorts have
higher levels of frailty compared with earlier cohorts of
equivalent age from the age of 70 and above.
▸ The increase in frailty in recent compared with earlier
cohorts is most prominent among the poorest individuals
with little evidence of any difference in frailty across cohorts
among the most afﬂuent.
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